Share

April 18, 2017; 88 (16) Article

Reference values for developing responsive functional outcome measures across the lifespan

Marnee J. McKay, Jennifer N. Baldwin, Paulo Ferreira, Milena Simic, Natalie Vanicek, Joshua Burns, For the 1000 Norms Project Consortium
First published March 22, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003847
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
194

Share

Article Information

vol. 88 no. 16 1512-1519
DOI: 
https://doi.org/10.1212/WNL.0000000000003847
PubMed: 
28330961
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 9, 2016
  • Accepted in final form January 20, 2017
  • First Published March 22, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Marnee J. McKay, MHlthSc,
    2. Jennifer N. Baldwin, BAppSc (Hons),
    3. Paulo Ferreira, PhD,
    4. Milena Simic, PhD,
    5. Natalie Vanicek, PhD,
    6. Joshua Burns, PhD;
    7. For the 1000 Norms Project Consortium
  1. Marnee J. McKay, MHlthSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Centre for Research Excellence in Neuromuscular Disorders National Health and Medical Research Council of Australia 2013-2016(NHMRC #1031893)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jennifer N. Baldwin, BAppSc (Hons),
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. Australian Postgraduate Award, 3.5 years 2. National Health and Medical Research Council of Australia Centre for Research Excellence in Neuromuscular Disorders (#1031893)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Australian Podiatry Education and Research Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Paulo Ferreira, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Milena Simic, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. These are not related to the study: 2016-2017 (CIC role) Dementia Collaborative Research Centres (DCRC) grants; HOMeCare: Caring for the dementia caregiver and their loved one via the HOMeCare Exercise and Mindfulness Program; $99,856 AUD 2015-2016 (CIB role) Medibank Health Research Funding; Integrating Mobile-health and Physical Activity to reduce the burden of Chronic low back pain Trial (IMPACT); $50,000 AUD Funding for this study: 2013 (CII role); Australian Podiatry Education & Research Fund (Australasian Podiatry Council); 1000 Norms Project: A deeper understanding of human variation; $4,332 AUD

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Natalie Vanicek, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Joshua Burns, PhD;
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Commercial Consultancies: Acceleron Pharma (September 2016)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NHMRC (National Health and Medical Research Council of Australia, Centre of Research Excellence #1031893 (2012-16), European Union Collaborative Research Scheme #1055131 (2012-16) (2) NIH (Inherited Neuropathies Consortium RDCRC #U54NS065712 supported by NINDS/ORDR and NCATS) (2015-2019)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Muscular Dystrophy Association USA (#250931) (2) CMT Association of Australia (3) Multiple Sclerosis Research Australia (4) Sydney Southeast Asia Centre (5) New Zealand Neuromuscular Research Foundation Trust (6) Thyne Reid Foundation (7) Elizabeth Lottie May Rosenthal Bone Bequest

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. For the 1000 Norms Project Consortium
    1. From the Arthritis and Musculoskeletal Research Group (M.J.M., J.N.B., P.F., M.S., J.B.), Faculty of Health Sciences, University of Sydney, New South Wales, Australia; Sport, Health and Exercise Science (N.V.), School of Life Sciences, University of Hull, UK; Faculty of Health Sciences (J.B.), University of Sydney and Sydney Children's Hospitals Network (Randwick and Westmead); and Paediatric Gait Analysis Service of New South Wales (J.B.), Children's Hospital at Westmead, Sydney, Australia.
    1. Correspondence to M.J. McKay: marnee.mckay{at}sydney.edu.au
    View Full Text

    Article usage

    Article usage: March 2017 to April 2019

    AbstractFullPdfSource
    Mar 2017730011Highwire
    Apr 201714871332Highwire
    May 2017336814Highwire
    Jun 201721389Highwire
    Jul 201725303Highwire
    Aug 201741959Highwire
    Sep 201713735Highwire
    Oct 201711013Highwire
    Nov 201710923Highwire
    Dec 201710855Highwire
    Jan 2018159125Highwire
    Feb 201812884Highwire
    Mar 2018156713Highwire
    Apr 2018146910Highwire
    May 201812787Highwire
    Jun 201810459Highwire
    Jul 201811189Highwire
    Aug 201810322Highwire
    Sep 201810117Highwire
    Oct 201810566Highwire
    Nov 201810044Highwire
    Dec 20185434Highwire
    Jan 20195914Highwire
    Feb 20197238Highwire
    Mar 20198302Highwire
    Apr 201911856Highwire

    Cited By...

    Disputes & Debates: Rapid online correspondence

    No comments have been published for this article.
    Comment

    NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

    • Stay timely. Submit only on articles published within the last 8 weeks.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • 200 words maximum.
    • 5 references maximum. Reference 1 must be the article on which you are commenting.
    • 5 authors maximum. Exception: replies can include all original authors of the article.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Topics Discussed

    Alert Me